Literature DB >> 15056056

Brain metastases in lung cancer.

Laurie E Gaspar1.   

Abstract

Brain metastases secondary to primary non-small cell and small cell lung cancer have become an important area of research. The brain is one of the most common sites of failure following treatment for locally advanced non-small cell lung cancer, often as the only site. Treatment strategies and the outcome for brain metastases from lung cancer may differ from brain metastases arising from other primary cancers. This article reviews the prognostic factors associated with brain metastases from lung cancer, as well as current treatment approaches with chemotherapy, surgery and radiation therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15056056     DOI: 10.1586/14737140.4.2.259

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  7 in total

1.  Eye-witnessing cancer-an ever-challenging experience.

Authors:  S Jurja
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 2.  Surgical management of advanced non-small cell lung cancer.

Authors:  Gonzalo Varela; Pascal Alexandre Thomas
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

Review 3.  Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.

Authors:  Meysam Yousefi; Tayyeb Bahrami; Arash Salmaninejad; Rahim Nosrati; Parisa Ghaffari; Seyed H Ghaffari
Journal:  Cell Oncol (Dordr)       Date:  2017-09-18       Impact factor: 6.730

4.  Association of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patients.

Authors:  B Cacho-Díaz; H Spínola-Maroño; L G Mendoza-Olivas; A Monroy-Sosa; G Reyes-Soto; O Arrieta
Journal:  Clin Transl Oncol       Date:  2019-03-22       Impact factor: 3.405

5.  WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

Authors:  Don X Nguyen; Anne C Chiang; Xiang H-F Zhang; Juliet Y Kim; Mark G Kris; Marc Ladanyi; William L Gerald; Joan Massagué
Journal:  Cell       Date:  2009-07-02       Impact factor: 41.582

6.  Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment.

Authors:  Laura E Stevens; Anna Arnal-Estapé; Don X Nguyen
Journal:  J Vis Exp       Date:  2018-06-28       Impact factor: 1.355

7.  Surgical intervention may be a therapeutic option for NSCLC patients with AJCC stage IV: a large population-based study.

Authors:  Haiyong Wang; Lei Yan; Cheng Li; Zhehai Wang
Journal:  Cancer Manag Res       Date:  2018-09-04       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.